Sumanth D. Prabhu, MD
Professor of Medicine and Cell, Developmental and Integrative Biology
Mary Gertrude Waters Chair of Cardiovascular Medicine
Director of the Division of Cardiovascular Disease
![]() |
Dr. Prabhu received a BS degree in Science from Penn State University and his MD degree from Jefferson Medical College in Philadelphia. He completed a residency in Internal Medicine at the University of Pittsburgh and a Cardiovascular Disease Fellowship at the University of Texas Health Science Center at San Antonio (UTHSCSA). After completing his fellowship, Dr. Prabhu remained on the faculty at UTHSCSA before moving to the University of Louisville. He joined UAB in 2011 as Professor of Medicine and Director of the Division of Cardiovascular Disease. He has published extensively on the mechanisms of ventricular dysfunction, cardiac remodeling and heart failure. Dr. Prabhu serves as a Consulting Editor for Circulation Research and is a member of the American Society for Clinical Investigation. |
||
Contact Information |
Tinsley Harrison Tower (THT), Room 311 1530 3rd Avenue South Birmingham, Alabama 35294-0006
|
||
Office Administrator |
Alicia Farley |
||
Professional |
|||
Training |
Cardiology Fellowship (Clinical and Research) Physician-Investigator Research Fellowship Internal Medicine Residency Medical Degree |
||
Board Certifications |
American Board of Internal Medicine – Cardiovascular Disease (1991, recertified 2001, 2011) |
||
Society Memberships |
Fellow, American College of Cardiology |
||
Editorial Board
|
American Journal of Physiology: Heart and Circulatory Physiology |
||
Clinical |
|||
Clinical Interests |
Heart failure, mechanical support |
||
Research |
|||
Research Interests |
Mechanisms of cardiac remodeling and stem cell-mediated repair in heart failure |
||
Selected Journal
|
Houser SR, Margulies KB, Murphy AM, Spinale F, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch W, on behalf of the American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res. 2012 (in press). Ismahil MA, Hamid T, Haberzettl P, Gu Y, Chandrasekar B, Srivastava S, Bhatnagar A Prabhu SD. Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2011;301:H2050-60 Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD. Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol. 2011;106:1193-205. Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD. Chronic NF-κB p65 activation in cardiomyocytes is essential for adverse remodeling, apoptosis, and endoplasmic reticulum stress in ischemic heart failure. Cardiovasc Res. 2011;89:129-38. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spinale FG, Riggs DW, Srivastava S, Xuan Y-T, Bhatnagar A, Bolli R, Prabhu SD. Cardioprotective and anti-apoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121:1912-1925. |
||
PubMed Listings |
|||
| Top |
|||

